Prior studies have suggested that TGF-β1 expression is correlated with amyloid deposition and vascular degeneration in central nervous system diseases, including Alzheimer’s disease (AD) and cerebral amyloid angiopathy [22]. This evidence concerns the gene TGFB1 and amyloidosis.